OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 153 filers reported holding OCULAR THERAPEUTIX INC in Q1 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $353,000 | -4.1% | 71,224 | +93.3% | 0.02% | -41.4% |
| Q3 2021 | $368,000 | +59.3% | 36,840 | +126.2% | 0.03% | +52.6% |
| Q2 2021 | $231,000 | -55.0% | 16,286 | -47.9% | 0.02% | -59.6% |
| Q1 2021 | $513,000 | +105.2% | 31,263 | -4.7% | 0.05% | +193.8% |
| Q3 2020 | $250,000 | +145.1% | 32,791 | +167.6% | 0.02% | +128.6% |
| Q2 2020 | $102,000 | -26.6% | 12,252 | -39.3% | 0.01% | -30.0% |
| Q3 2018 | $139,000 | -23.2% | 20,190 | -6.8% | 0.01% | -65.5% |
| Q4 2016 | $181,000 | +40.3% | 21,663 | +57.8% | 0.03% | +163.6% |
| Q4 2015 | $129,000 | -14.6% | 13,731 | +27.5% | 0.01% | -15.4% |
| Q3 2015 | $151,000 | -54.1% | 10,772 | -31.4% | 0.01% | -64.9% |
| Q2 2015 | $329,000 | -16.1% | 15,700 | +68.0% | 0.04% | -7.5% |
| Q1 2015 | $392,000 | – | 9,348 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |